{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:20:12Z","timestamp":1785417612509,"version":"3.56.0"},"posted":{"date-parts":[[2026,5,27]]},"group-title":"Pharmacology and Toxicology","reference-count":90,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"award":["R01HL122937"],"award-info":[{"award-number":["R01HL122937"]}],"id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"publisher"}]},{"award":["RO1HL150007"],"award-info":[{"award-number":["RO1HL150007"]}],"id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,5,27]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Liver sinusoidal endothelial cells (LSECs) are increasingly recognized as a critical yet underexplored cell type in anti-fibrotic drug development. This study presents a computational drug screening platform integrating LSEC-specific transcriptomic analysis across simple steatosis, fibrotic nonalcoholic steatohepatitis (NASH), and cirrhosis, with tiered gene signature selection combining machine learning, large language model-assisted curation, gene safety assessment, and Connectivity Map-based screening using human endothelial perturbational profiles. The platform identifies 6 clinical-stage and 8 preclinical candidates with LSEC-protective potential. Among these, vorinostat (SAHA), a clinically approved histone deacetylase (HDAC) inhibitor, is selected for experimental validation. In hepatocyte-specific Asah1-deficient mice fed a Paigen diet, SAHA attenuates hepatic inflammation, fibrosis, LSEC dysfunction, and portal hemodynamic abnormalities, with effects confirmed in a hepatotoxin (CCl\n                  <jats:sub>4<\/jats:sub>\n                  )-induced fibrosis model. High mobility group box 1 (HMGB1) is identified as a key hepatocyte-derived paracrine mediator of LSEC injury through Transwell co-culture and glycyrrhizin rescue. Vorinostat dose-dependently reverses HMGB1-induced LSEC dysfunction across inflammation, capillarization, fibrogenesis, and vasoconstriction, associated with endothelial transcription factor reprogramming including KLF2 upregulation, validated in primary LSECs and in vivo. SAHA also protected LSECs from TNF-\u03b1-induced inflammation and reduced monocyte adhesion. These findings establish an LSEC-focused drug repurposing framework and identify candidates for LSEC-protective anti-fibrotic therapy.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>GRAPHICAL ABSTRACT<\/jats:title>\n                  <jats:fig id=\"ufig1\" position=\"float\" orientation=\"portrait\" fig-type=\"figure\">\n                    <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"727430v1_ufig1\" position=\"float\" orientation=\"portrait\"\/>\n                  <\/jats:fig>\n                <\/jats:sec>","DOI":"10.64898\/2026.05.23.727430","type":"posted-content","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:55:16Z","timestamp":1779929716000},"source":"Crossref","is-referenced-by-count":0,"title":["An LSEC-focused computational drug repurposing platform for liver fibrosis: Identification of vorinostat and other LSEC-protective candidates"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1589-345X","authenticated-orcid":false,"given":"Rui","family":"Zuo","sequence":"first","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"},{"name":"Department of Gastroenterology and Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Z.","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra K.","family":"Moura","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Lan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0155-2328","authenticated-orcid":false,"given":"Mingfu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"},{"name":"Heart and Kidney Institute, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"},{"name":"Heart and Kidney Institute, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-3013","authenticated-orcid":false,"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA"},{"name":"Heart and Kidney Institute, College of Pharmacy, University of Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026052918253034000_2026.05.23.727430v1.1","doi-asserted-by":"crossref","unstructured":"Roehlen, N. , E. Crouchet , and T.F. Baumert , Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 2020. 9(4).","DOI":"10.3390\/cells9040875"},{"key":"2026052918253034000_2026.05.23.727430v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017"},{"issue":"7","key":"2026052918253034000_2026.05.23.727430v1.3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","article-title":"Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis","volume":"23","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026052918253034000_2026.05.23.727430v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32517-6"},{"issue":"6","key":"2026052918253034000_2026.05.23.727430v1.5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2468-1253(23)00068-7","article-title":"Semaglutide 2\u00b74 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026052918253034000_2026.05.23.727430v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.38"},{"key":"2026052918253034000_2026.05.23.727430v1.7","doi-asserted-by":"crossref","first-page":"1734449","DOI":"10.3389\/fphar.2025.1734449","article-title":"From mechanisms to anti-fibrotic drugs in hepatic stellate cell research: a global bibliometric analysis with patent and clinical perspectives (2000-2025)","volume":"16","year":"2025","journal-title":"Front Pharmacol"},{"issue":"3","key":"2026052918253034000_2026.05.23.727430v1.8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3350\/cmh.2024.0022","article-title":"Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis","volume":"30","year":"2024","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"2026052918253034000_2026.05.23.727430v1.9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3350\/cmh.2024.0343","article-title":"Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on \u201cLiver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis\u201d","volume":"30","year":"2024","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"2026052918253034000_2026.05.23.727430v1.10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2025.10.017","article-title":"The role of liver sinusoidal endothelial cells in liver diseases: Key players in health and pathology","volume":"84","year":"2026","journal-title":"Journal of Hepatology"},{"key":"2026052918253034000_2026.05.23.727430v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00411-3"},{"key":"2026052918253034000_2026.05.23.727430v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.08.026"},{"key":"2026052918253034000_2026.05.23.727430v1.13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27376"},{"key":"2026052918253034000_2026.05.23.727430v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.95"},{"key":"2026052918253034000_2026.05.23.727430v1.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.12.017"},{"issue":"9","key":"2026052918253034000_2026.05.23.727430v1.16","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.cell.2026.02.001","article-title":"Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis","volume":"189","year":"2026","journal-title":"Cell"},{"key":"2026052918253034000_2026.05.23.727430v1.17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1132939"},{"issue":"11","key":"2026052918253034000_2026.05.23.727430v1.18","doi-asserted-by":"crossref","first-page":"103233","DOI":"10.1016\/j.isci.2021.103233","article-title":"Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver","volume":"24","year":"2021","journal-title":"iScience"},{"key":"2026052918253034000_2026.05.23.727430v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.08.033"},{"key":"2026052918253034000_2026.05.23.727430v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1631-3"},{"key":"2026052918253034000_2026.05.23.727430v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/S41587-023-01767-Y"},{"key":"2026052918253034000_2026.05.23.727430v1.22","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp616"},{"key":"2026052918253034000_2026.05.23.727430v1.23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007"},{"key":"2026052918253034000_2026.05.23.727430v1.24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7"},{"key":"2026052918253034000_2026.05.23.727430v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELS.2015.12.004"},{"key":"2026052918253034000_2026.05.23.727430v1.26","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"key":"2026052918253034000_2026.05.23.727430v1.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2010.00740.x"},{"key":"2026052918253034000_2026.05.23.727430v1.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2005.00503.x"},{"key":"2026052918253034000_2026.05.23.727430v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.06.010"},{"key":"2026052918253034000_2026.05.23.727430v1.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0060-1"},{"key":"2026052918253034000_2026.05.23.727430v1.31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1153"},{"key":"2026052918253034000_2026.05.23.727430v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.049"},{"key":"2026052918253034000_2026.05.23.727430v1.33","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2269-7_19"},{"key":"2026052918253034000_2026.05.23.727430v1.34","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"2026052918253034000_2026.05.23.727430v1.35","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAB294"},{"issue":"3","key":"2026052918253034000_2026.05.23.727430v1.36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajpath.2024.11.003","article-title":"Ablation of Hepatic Asah1 Gene Disrupts Hepatic Lipid Homeostasis and Promotes Fibrotic Nonalcoholic Steatohepatitis in Mice","volume":"195","year":"2025","journal-title":"Am J Pathol"},{"issue":"5","key":"2026052918253034000_2026.05.23.727430v1.37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00109-025-02542-z","article-title":"Cardiovascular dysfunction and altered lysosomal signaling in a murine model of acid sphingomyelinase deficiency","volume":"103","year":"2025","journal-title":"J Mol Med (Berl"},{"issue":"23","key":"2026052918253034000_2026.05.23.727430v1.38","first-page":"e037460","article-title":"Coronary Microvascular Dysfunction Is Associated With Augmented Lysosomal Signaling in Hypercholesterolemic Mice","volume":"13","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026052918253034000_2026.05.23.727430v1.39","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAC1000"},{"key":"2026052918253034000_2026.05.23.727430v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.06.006"},{"key":"2026052918253034000_2026.05.23.727430v1.41","doi-asserted-by":"crossref","unstructured":"You, W. , et al., Unlocking therapeutic potential of amlexanox in MASH with insights into bile acid metabolism and microbiome. NPJ Gut Liver, 2025. 2.","DOI":"10.1038\/s44355-024-00015-7"},{"issue":"5","key":"2026052918253034000_2026.05.23.727430v1.42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.hbpd.2018.09.013","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-\u03b21 signal pathway","volume":"17","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2026052918253034000_2026.05.23.727430v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.02.043"},{"key":"2026052918253034000_2026.05.23.727430v1.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35653-4"},{"key":"2026052918253034000_2026.05.23.727430v1.45","doi-asserted-by":"crossref","unstructured":"Foglia, B. , et al., ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. Int J Mol Sci, 2019. 20(11).","DOI":"10.3390\/ijms20112700"},{"key":"2026052918253034000_2026.05.23.727430v1.46","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23189"},{"issue":"3","key":"2026052918253034000_2026.05.23.727430v1.47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1142\/S0192415X12500371","article-title":"Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling","volume":"40","year":"2012","journal-title":"Am J Chin Med"},{"issue":"44","key":"2026052918253034000_2026.05.23.727430v1.48","first-page":"e08751","article-title":"AI-Assisted Drug Re-Purposing for Human Liver Fibrosis","volume":"12","year":"2025","journal-title":"Adv Sci (Weinh"},{"key":"2026052918253034000_2026.05.23.727430v1.49","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.134288"},{"key":"2026052918253034000_2026.05.23.727430v1.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.10.016"},{"issue":"3","key":"2026052918253034000_2026.05.23.727430v1.51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/HEP.0000000000000569","article-title":"Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A\/HIF-1\u03b1 transcriptional complex","volume":"79","year":"2024","journal-title":"Hepatology"},{"key":"2026052918253034000_2026.05.23.727430v1.52","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30093"},{"key":"2026052918253034000_2026.05.23.727430v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.05.011"},{"key":"2026052918253034000_2026.05.23.727430v1.54","doi-asserted-by":"publisher","DOI":"10.1002\/path.2888"},{"key":"2026052918253034000_2026.05.23.727430v1.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.10.007"},{"key":"2026052918253034000_2026.05.23.727430v1.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.09.016"},{"key":"2026052918253034000_2026.05.23.727430v1.57","doi-asserted-by":"crossref","unstructured":"Yan, T. , et al., Hepatocyte-specific CCAAT\/enhancer binding protein \u03b1 restricts liver fibrosis progression. J Clin Invest, 2024. 134(7).","DOI":"10.1172\/JCI166731"},{"key":"2026052918253034000_2026.05.23.727430v1.58","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24701"},{"key":"2026052918253034000_2026.05.23.727430v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20303-z"},{"issue":"6","key":"2026052918253034000_2026.05.23.727430v1.60","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-\u03b3","volume":"1","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026052918253034000_2026.05.23.727430v1.61","doi-asserted-by":"publisher","DOI":"10.1042\/CS20140823"},{"key":"2026052918253034000_2026.05.23.727430v1.62","doi-asserted-by":"crossref","unstructured":"Abad-Jord\u00e0, L. , et al., Hepatocyte-derived extracellular vesicles promote endothelial dedifferentiation in chronic liver disease through the miR-153-3p-pyroptosis axis. Hepatology, 2025.","DOI":"10.1097\/HEP.0000000000001567"},{"key":"2026052918253034000_2026.05.23.727430v1.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.07.019"},{"key":"2026052918253034000_2026.05.23.727430v1.64","doi-asserted-by":"crossref","unstructured":"Kang, J. , et al., Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis. JCI Insight, 2023. 8(3).","DOI":"10.1172\/jci.insight.165369"},{"key":"2026052918253034000_2026.05.23.727430v1.65","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M063412"},{"key":"2026052918253034000_2026.05.23.727430v1.66","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31050"},{"key":"2026052918253034000_2026.05.23.727430v1.67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28252"},{"key":"2026052918253034000_2026.05.23.727430v1.68","doi-asserted-by":"publisher","DOI":"10.1038\/srep28786"},{"key":"2026052918253034000_2026.05.23.727430v1.69","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.12.037"},{"key":"2026052918253034000_2026.05.23.727430v1.70","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83885"},{"issue":"12","key":"2026052918253034000_2026.05.23.727430v1.71","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/liv.15103","article-title":"A genetic hypothesis for burnt-out steatohepatitis","volume":"41","year":"2021","journal-title":"Liver Int"},{"issue":"10","key":"2026052918253034000_2026.05.23.727430v1.72","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41587-023-02033-x","article-title":"Discovery of sparse, reliable omic biomarkers with Stabl","volume":"42","year":"2024","journal-title":"Nat Biotechnol"},{"key":"2026052918253034000_2026.05.23.727430v1.73","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-3320-z"},{"key":"2026052918253034000_2026.05.23.727430v1.74","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12590"},{"key":"2026052918253034000_2026.05.23.727430v1.75","doi-asserted-by":"crossref","unstructured":"Yoon, S. , G. Kang , and G.H. Eom , HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases. Int J Mol Sci, 2019. 20(6).","DOI":"10.3390\/ijms20061329"},{"issue":"15","key":"2026052918253034000_2026.05.23.727430v1.76","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.7150\/ijbs.87332","article-title":"Acteoside ameliorates hepatic ischemia-reperfusion injury via reversing the senescent fate of liver sinusoidal endothelial cells and restoring compromised sinusoidal networks","volume":"19","year":"2023","journal-title":"Int J Biol Sci"},{"key":"2026052918253034000_2026.05.23.727430v1.77","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12420"},{"key":"2026052918253034000_2026.05.23.727430v1.78","doi-asserted-by":"crossref","first-page":"9993240","DOI":"10.1155\/2021\/9993240","article-title":"Recombinant High-Mobility Group Box 1 (rHMGB1) Promotes NRF2-Independent Mitochondrial Fusion through CXCR4\/PSMB5-Mediated Drp1 Degradation in Endothelial Cells","volume":"2021","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"2026052918253034000_2026.05.23.727430v1.79","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2010.3647"},{"key":"2026052918253034000_2026.05.23.727430v1.80","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.314402"},{"key":"2026052918253034000_2026.05.23.727430v1.81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3465"},{"issue":"16","key":"2026052918253034000_2026.05.23.727430v1.82","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1177\/1535370220949148","article-title":"Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells","volume":"245","year":"2020","journal-title":"Exp Biol Med (Maywood"},{"key":"2026052918253034000_2026.05.23.727430v1.83","first-page":"1160053","article-title":"An update on animal models of liver fibrosis","volume":"10","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2026052918253034000_2026.05.23.727430v1.84","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C500200200"},{"issue":"4","key":"2026052918253034000_2026.05.23.727430v1.85","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jcmgh.2020.12.007","article-title":"Single-Cell Transcriptomics Reveals Zone-Specific Alterations of Liver Sinusoidal Endothelial Cells in Cirrhosis","volume":"11","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026052918253034000_2026.05.23.727430v1.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.03.009"},{"key":"2026052918253034000_2026.05.23.727430v1.87","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.2307"},{"issue":"2","key":"2026052918253034000_2026.05.23.727430v1.88","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/jcmm.14817","article-title":"Dual TBK1\/IKK\u025b inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice","volume":"24","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2026052918253034000_2026.05.23.727430v1.89","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00041.2019"},{"issue":"1","key":"2026052918253034000_2026.05.23.727430v1.90","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/s41598-022-09225-6","article-title":"Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy","volume":"12","year":"2022","journal-title":"Sci Rep"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.05.23.727430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:25:45Z","timestamp":1780104345000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.05.23.727430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":90,"URL":"https:\/\/doi.org\/10.64898\/2026.05.23.727430","relation":{},"subject":[],"published":{"date-parts":[[2026,5,27]]},"subtype":"preprint"}}